Association Between Postoperative Nausea Severity and Pain Intensity in Patients Experiencing Postoperative Nausea and Vomiting After Minor Oral and Maxillofacial Surgery: A Retrospective Cohort Study. [PDF]
Horikoshi Y +7 more
europepmc +1 more source
Purpose The main aim of the present study was to assess antiemetic prescriptions used during chemotherapy and identify if these are in agreement with internationally agreed consensus guidelines (MASCC/ASCO).
Brearley, S. G. +2 more
core
Conflict-Related Disruption of Oncology Drug Supply in the Gulf and Measures to Maintain Cancer Care Continuity. [PDF]
Abusanad A, Esba LCA, Kullab S.
europepmc +1 more source
ABSTRACT Aims To evaluate the real‐world effectiveness, safety and patient‐reported outcomes of biosynthetic semaglutide in adults with type 2 diabetes mellitus (T2DM) receiving routine outpatient care in a cost‐constrained setting. Methods This 30‐week, prospective, multicentre, non‐interventional study enrolled adults with T2DM initiating ...
Arshad Hussain +9 more
wiley +1 more source
Emergency Department Triage Nurses' Scope of Practice: An Observational Study
ABSTRACT Aim To explore emergency department triage nurses' scope of practice and activities related to their triage role and management of patients located in emergency department waiting areas. Design Exploratory, descriptive, observational study using naturalistic decision making.
Julie Considine +8 more
wiley +1 more source
Oliceridine versus sufentanil: a systematic review and meta-analysis of postoperative nausea and vomiting. [PDF]
Wan J +5 more
europepmc +1 more source
Transcutaneous auricular vagus nerve stimulation for postoperative nausea and vomiting in gynecological laparoscopic surgery: a randomized controlled trial protocol. [PDF]
Li P +5 more
europepmc +1 more source
Evaluating ChatGPT's accuracy in predicting postoperative nausea and vomiting risk and antiemetic prophylaxis planning: A study on simulated patient profiles. [PDF]
Ahmed H +5 more
europepmc +1 more source
Patient factors and costs associated with prophylactic neurokinin-1 receptor antagonist use among women with invasive breast cancer. [PDF]
Kamat S, Brown BR, Cohen SA, Vyas A.
europepmc +1 more source

